Published September 25, 2015 | Version v1
Journal article

Caffeic acid phenethyl ester inhibits 3-MC-induced CYP1A1 expression through induction of hypoxia-inducible factor-1α

  • 1. Department of Toxicology, College of Pharmacy, Chungnam National University, Daejeon (Korea, Republic of)
  • 2. Division of Life Science, Korea Basic Science Institute, Daejeon (Korea, Republic of)

Description

Caffeic acid phenethyl ester (CAPE), a natural component of propolis, is reported to have anticarcinogenic properties, although its precise chemopreventive mechanism remains unclear. In this study, we examined the effects of CAPE on 3-methylcholanthrene (3-MC)-induced CYP1A1 expression and activities. CAPE reduced the formation of the benzo[a]pyrene-DNA adduct. Moreover, CAPE inhibited 3-MC-induced CYP1A1 activity, mRNA expression, protein level, and promoter activity. CAPE treatment also decreased 3-MC-inducible xenobiotic-response element (XRE)-linked luciferase, aryl hydrocarbons receptor (AhR) transactivation and nuclear localization. CAPE induced hypoxia inducible factor-1α (HIF-1α) protein level and HIF-1α responsible element (HRE) transcriptional activity. CAPE-mediated HIF-1α reduced 3-MC-inducible CYP1A1 protein expression. Taken together, CAPE decreases 3-MC-mediated CYP1A1 expression, and this inhibitory response is associated with inhibition of AhR and HIF-1α induction. - Highlights: • CAPE reduced the formation of the benzo[a]pyrene-DNA adduct. • CAPE inhibited 3-MC-induced CYP1A1 expression. • CAPE induced HIF-1α induction. • CAPE-mediated HIF-1α reduced 3-MC-inducible CYP1A1 expression

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2015.08.060

Additional details

Identifiers

DOI
10.1016/j.bbrc.2015.08.060;
PII
S0006-291X(15)30450-2;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
465
Journal Issue
3
Journal Page Range
p. 562-568
ISSN
0006-291X
CODEN
BBRCA9

Optional Information

Copyright
Copyright (c) 2015 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.